This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. advanced 4.6% to $34.17 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.3% to 18,188.59 and the Dow Jones Industrial Average rising 1.4% to 42,583.32.
This was the stock's second consecutive day of gains.
Moderna Inc. closed 80.0% short of its 52-week high of $170.47, which the company achieved on May 24th.
The stock outperformed some of its competitors, as Johnson & Johnson fell 0.2% to $163.29, Pfizer Inc. fell 0.5% to $26.14, and Gilead Sciences Inc. fell 0.32% to $106.74.
Trading volume totaled 10.5 million, compared to the 50-day average of 12.0 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 24, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。